Attitudes of cancer patients toward ctDNA-based liquid biopsy for follow-up
Source
Molecular Oncology - ISSN 1574-7891- (2026) p.
Improved adverse event reporting : it's about time
Source
Journal of the National Cancer Institute - ISSN 0027-8874- (2026) p.
Access to cancer clinical trials in Europe: when trial availability does not match patient need
Source
ESMO Open - ISSN 2059-7029-11:10 (2026) p.
Developing cancer-control policies to address the cancer burden among young adults
Source
Nature medicine - ISSN 1078-8956- (2026) p.
Beyond convenience : does subcutaneous pembrolizumab add value for patients and health systems?
Source
Journal of clinical oncology - ISSN 0732-183X-44:20 (2026) p. 1860-1864